Pharmacological validation of targets regulating CD14 during macrophage differentiation

Jimenez-Duran, Gisela, Luque-Martin, Rosario, Patel, Meghana, Koppe, Emma, Bernard, Sharon, Sharp, Catriona, Buchan, Natalie, Rea, Ceara, de Winther, Menno P.J., Turan, Nil, Angell, Davina, Wells, Christine A., Cousins, Rick, Mander, Palwinder K. and Masters, Seth L. 2020. Pharmacological validation of targets regulating CD14 during macrophage differentiation. EBioMedicine 61 , 103039. 10.1016/j.ebiom.2020.103039

Preview

PDF - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (17MB) | Preview

Abstract

The signalling receptor for LPS, CD14, is a key marker of, and facilitator for, pro-inflammatory macrophage function. Pro-inflammatory macrophage differentiation remains a process facilitating a broad array of disease pathologies, and has recently emerged as a potential target against cytokine storm in COVID19. Here, we perform a whole-genome CRISPR screen to identify essential nodes regulating CD14 expression in myeloid cells, using the differentiation of THP-1 cells as a starting point. This strategy uncovers many known pathways required for CD14 expression and regulating macrophage differentiation while additionally providing a list of novel targets either promoting or limiting this process. To speed translation of these results, we have then taken the approach of independently validating hits from the screen using well-curated small molecules. In this manner, we identify pharmacologically tractable hits that can either increase CD14 expression on non-differentiated monocytes or prevent CD14 upregulation during macrophage differentiation. An inhibitor for one of these targets, MAP2K3, translates through to studies on primary human monocytes, where it prevents upregulation of CD14 following M-CSF induced differentiation, and pro-inflammatory cytokine production in response to LPS. Therefore, this screening cascade has rapidly identified pharmacologically tractable nodes regulating a critical disease-relevant process.

Item Type:	Article
Date Type:	Publication
Schools:	Medicine
Publisher:	Elsevier
ISSN:	2352-3964
Date of First Compliant Deposit:	22 October 2020
Date of Acceptance:	14 September 2020
Last Modified:	05 May 2023 07:53
URI:	https://orca.cardiff.ac.uk/id/eprint/135867

Citation Data

Cited 9 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item